JPRN-UMIN000012074尚未招募1 期
Phase I/II trial of S-1+Nedaplatin+Cetuximab for recurrent/metastatic head and neck squamous cell carcinoma - Phase I/II trial of S-1+Nedaplatin+Cetuximab for recurrent/metastatic head and neck cancer
Kyorin University School of Medicine, Department of Otolaryngology0 个研究点目标入组 30 人开始时间: 2013年11月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Past history of allergy against S-1, Nedaplati or cetuximab 2) pregnancy or the man who wants partner's pregnancy 3) active double cancer 4) active infection disesase 5) Current administration of Flucytosine, fenitoin or warfarin 6) Positivity for hepatitis B or Hepatitis C antigen 7) severe skin disesase 8) interstitial pneumonia 9) severe diarrhea 10) severe renal disease 11) Other significant disease that in the investigator's opinion would exclude the subject from the trial
研究者
相似试验
招募中
2 期
Phase II trial of Nedaplatin/S-1/Cetuximab combination therapy for Recurrence or Metastatic Squamous cell carcinoma of the Head and NeckRecurrence or Metastatic Squamous cell carcinoma of the Head and NeckJPRN-UMIN000011497Kinki University Faculty of Medicine, Department of Medical Oncology40
已完成
2 期
Phase II trial of S-1 plus Cetuximab combination chemotherapy for advanced recurrent/metastatic carcinoma of the oral cavityAdvanced recurrent/metastatic carcinoma of the oral cavityJPRN-UMIN000024371Osaka University20
已完成
2 期
Phase II trial of S-1+oxaliplatin+Cetuximab as first-line treatment in patients with kras-wild type unresectable advanced colorectal cancer - KODK 9colorectal cancerJPRN-UMIN000008963Department of Surgery Keio University School of Medicine35
已完成
2 期
Phase II trial of S-1 plus Cetuximab combination therapy in patients inappropriate for platinum-based therapy with recurrent/metastatic squamous cell carcinoma of the head and neckJPRN-UMIN000015123Hokkaido University21
招募中
不适用
Phase I trial of Cetuximab combined with S-1 and irrinotecan in advanced colorectal cancercolorectal cancerJPRN-UMIN000003703Toho University school of Medicine10